Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia

SIMPLE SUMMARY: Although the majority of patients with acute myeloid leukemia (AML) reach a morphologic complete remission after high-dose chemotherapy, the majority of them face a relapse within a few years. Detection of residual cells, persisting in a considerably small amount, has shown to be pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Vonk, Christian M., Al Hinai, Adil S. A., Hanekamp, Diana, Valk, Peter J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582498/
https://www.ncbi.nlm.nih.gov/pubmed/34771594
http://dx.doi.org/10.3390/cancers13215431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582498/
https://www.ncbi.nlm.nih.gov/pubmed/34771594
http://dx.doi.org/10.3390/cancers13215431

Ejemplares similares